Nabil Khan M.D.

Nabil Khan MD is a seasoned professional in clinical research and operations with extensive experience in monitoring and managing complex clinical studies across various therapeutic areas, including respiratory syncytial virus, ophthalmology, and neurology. Currently serving as Principal CRA at PPD, Nabil monitors investigator sites focusing on compliance and risk management. Previous roles include Senior CRA positions at ICON plc and IQVIA, where responsibilities included site selection, initiation, and monitoring. As Director of Clinical Operations at Impact Physician Group, Nabil oversaw operations across multiple healthcare facilities, driving improvements in patient care and operational expansion. Educationally, Nabil holds a Doctor of Medicine degree from Xavier University School of Medicine and has also served as an adjunct professor in pharmacology and nutrition.